Free tool
Oncology stocks
We cover 4 companies grouped under the Oncology theme. The median market value in the group is $28.47M. Across the group, the median move over the past trading day is −1.30%. Price change over the past year runs from −81.2% to −26.3% across the middle 80 percent of the group, with a median of −76.5%.
Other lists in this group
SaaSAI applicationsCybersecuritySemiconductor designSemiconductor equipmentFintech softwarePayment processingEcommerce marketplacesStreaming mediaGaming softwareOncologyRare diseaseMedical devicesCell therapyDiagnosticsRegional banksAsset managementGold miningCryptocurrency and digital assetsSpecialty chemicalsAll stocks
Table
4 of 319 companies match these filters.Clear filters
| Ticker | Company | Market cap (USD) | Size | 1Y return | Next report |
|---|---|---|---|---|---|
| 0J4V.L | Heron Therapeutics, Inc. | $82.85M | Micro cap | −78.12% | Nov 3, 2026 |
| KPTI | Karyopharm Therapeutics Inc. Common Stock | $44.46M | Micro cap | −74.90% | Nov 3, 2026 |
| PDSB | PDS Biotechnology Corporation | $12.49M | Micro cap | −82.56% | Nov 12, 2026 |
| CRIS | Curis, Inc. | $3.86M | Micro cap | −5.52% | Nov 5, 2026 |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.